LEK Consulting
About LEK Consulting
1 article about LEK Consulting
-
Study Documents Biopharmaceutical Industry's Increased Investment in Personalized Cancer Treatments, Including Immunotherapies, Underlining Importance of Reimbursement Policies That Facilitate Sustainable Access
10/30/2019
A quantitative analysis conducted by L.E.K. Consulting and published by the Personalized Medicine Coalition shows that the biopharmaceutical industry is deeply invested in developing immunotherapies and other cancer treatments that are designed to influence the activity of specific molecules involved in the growth of cancerous cells.